Microsatellite instability and p53 expression in gallbladder carcinomas

Diagnostic Molecular Pathology

Volumn 12, Issue 2, 2003, Pages 96-102

  Sessa, Fausto ^b   Furlan, Daniela ^b   Genasetti, Anna ^b   Billo, Paola ^b   Feltri, Maddalena ^b   Capella, Carlo ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

^b NONE

Author keywords

Gallbladder cancer; Microsatellite instability; p53

Indexed keywords

GENE PRODUCT; PROTEIN MLH1; PROTEIN MSH2; PROTEIN P53;

ARTICLE; BLADDER CARCINOMA; GALLBLADDER CARCINOMA; GENE LOCUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROSATELLITE INSTABILITY; MUCINOUS CARCINOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038102366     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200306000-00005     Document Type: Article

References (38)

1. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder. Histologic type, stage of the disease, grade, and survival rate. Cancer 1992;70:1493-7.
2. Wistuba II, Miquel JF, Gazdar AF, et al. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999;30:21-5.
3. Chang HJ, Kim SW, Kim YT, et al. Loss of heterozygosity in dysplasia and carcinoma of the gallbladder. Mod Pathol 1999;12:763-9.
4. Gorunova L, Parada LA, Limon J, et al. Nonrandom chromosomal aberrations and cytogenetic heterogeneity in gallbladder carcinomas. Gen Chrom Cancer 1999;26:312-21.
5. Hidaka E, Yanagisawa A, Sakai Y, et al. Losses of heterozygosity on chromosome 17p and 9p/18q may play important roles in early and advanced phases of gallbladder carcinogenesis. J Cancer Res Clin Oncol 1999;125:439-43.
6. Matsuo K, Kuroki T, Kitaoka F, et al. Loss of heterozygosity of chromosome 16q in gallbladder carcinoma. J Surg Res 2002;102:133-6.
7. Wistuba II, Tang M, Maitra A, et al. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res 2001;61:3795-800.
8. Itoi T, Watanabe H, Ajioka Y, et al. APC, K-ras codon 12 mutations and correlation of p53 gene expression in carcinoma and adenoma of the gallbladder suggest two genetic pathway in gallbladder carcinogenesis. Pathol Int 1996;46:333-40.
9. Watanabe M, Asaka M, Tanaka J, et al. Point mutations of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994;107:1147-53.
10. Wistuba II, Gadzar AF, Roa I, et al. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996;27:360-5.
11. Yoshida S, Todoroki T, Ichikawa Y, et al. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Cancer Res 1995;55:2756-60.
12. Yoshida T, Sugai T, Habano W, et al. Microsatellite instability in gallbladder carcinoma: two independent genetic pathways of gallbladder carcinogenesis. J Gastroenterol 2000;35:768-74.
13. Jiricny J. Replication errors: challenging the genome. Embo J 1998;17:6427-36.
14. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutation of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
15. Peltomaki OP. DNA mismatch repair and cancer. Mut Res 2001;488:77-85.
16. Achille A, Biasi MO, Zamboni G, et al. Cancers of the papilla of water: mutator phenotype is associated with good prognosis. Clin Cancer Res 1997;3:1841-7.
17. Chiaravalli AM, Furlan D, Facco C, et al. Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with high instability in microsatellite sequences. Virch Arch 2001;438:39-48.
18. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998;95:6870-5.
19. Simpkins SB, Bocker T, Swisher EM, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genetics 1999;8:661-6.
20. Yamamoto H, Itoh F, Nakamura H, et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001;61:3139-44.
21. Calin G, Gafà R, Tibiletti MG, et al. Genetic progression in microsatellite instability high (MSI-H) colon cancers correlates with clinico-pathologic parameters: a study of the TGFβRII, BAX, hMSH3, hMSH6, IGFIIR and BLM genes. Int J Cancer 2000;89:230-5.
22. Goggins M, Offerhaus G, Johan A, et al. Pancreatic adenocarcinomas with DNA Replication Errors (RER+) are associated with Wild Type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER+. Am J Pathol 1998;156:1501-7.
23. Luinetti O, Fiocca R, Villani L, et al. Genetic pattern, histologic structure and cellular phenotype in early and advanced gastric cancer: evidence for structure-related genetic subsets and for loss of glandular structure during progression of some tumors. Hum Pathol 1998;29:702-9.
24. Tibiletti MG, Furlan D, Taborelli M, et al. Microsatellite instability in endometrial cancer: relation to histologic subtypes. Gynecol Oncol 1999;73:247-52.
25. Lengauer C, Kinzler KV, Vogelstin B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
26. Elsaleh M, Joseph D, Grieu F, et al. Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer. Lancet 2000;355:1745-50.
27. Albores-Saavedra J, Henson DE, Sobin LH. WHO: Histological Typing of Tumors of the Gallbladder and Extrahepatic Bile Ducts (ed 2). Springer Verlag: Berlin, 1991
28. Sessa F, Bonato M, Frigerio B, et al. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 1990;98:1655-65.
29. Hoang JM, Cottu PH, Thuille B, et al. Bat-26, an indicator of the Replication Error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-3.
30. Zhou X-P, Hoang JM, Li Y-J, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Gene Chromosomes Cancer 1998;21:101-7.
31. Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcomein young patients with colorectal cancer. N Engl J Med 2000;342:69-77.
32. Halling KC, Harper J, Moskaluk CA, et al. Origin of microsatellite instability in gastric cancer. Am J Pathol 1999;155:205-11.
33. Kim YT, Kim J, Jang YH, et al. Genetic alterations in gallbladder adenoma, dysplasia and carcinoma. Cancer Lett 2001;169:59-68.
34. Sessa F, Bonato M, Bisoni D, et al. Evidence of a wide heterogeneity in cancer cell population in gallbladder adenocarcinomas. Mod Pathol 1997;147A.
35. Marcus VA, Madlensky L, Gryfe R, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repairdeficient tumors. Am J Surg Pathol 1999;23:1248-55.
36. Kuo KK, Sato N, Mizumoto K, et al. Centrosome abnormalities in human carcinomas of the gallbladder and intrahepatic and extrahepatic bile ducts. Hepatology 2000;31:59-64.
37. Kondo Y, Kanai Y, Sakamoto M, et al. Microsatellite instability associated with hepatocarcinogenesis. J Hepatol 1999;31:529-36.
38. Wang L, Bani-Hani A, Montoya DP, et al. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Int J Oncol 2001;19:567-70.